| Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth G Germano, S Lamba, G Rospo, L Barault, A Magrì, F Maione, M Russo, ... Nature 552 (7683), 116-120, 2017 | 560 | 2017 |
| Is there a role for IGF1R and c-MET pathways in resistance to cetuximab in metastatic colorectal cancer? A Inno, M Di Salvatore, T Cenci, M Martini, A Orlandi, A Strippoli, ... Clinical colorectal cancer 10 (4), 325-332, 2011 | 110 | 2011 |
| Pyrotinib plus capecitabine for patients with human epidermal growth factor receptor 2-positive breast cancer and brain metastases (PERMEATE): a multicentre, single-arm, two … M Yan, Q Ouyang, T Sun, L Niu, J Yang, L Li, Y Song, C Hao, Z Chen, ... The Lancet Oncology 23 (3), 353-361, 2022 | 91 | 2022 |
| Anti‐tumour and anti‐angiogenetic effects of zoledronic acid on human non‐small‐cell lung cancer cell line M Di Salvatore, A Orlandi, C Bagalà, M Quirino, A Cassano, A Astone, ... Cell proliferation 44 (2), 139-146, 2011 | 91 | 2011 |
| Class 1, 2, and 3 BRAF-Mutated Metastatic Colorectal Cancer: A Detailed Clinical, Pathologic, and Molecular Characterization M Schirripa, P Biason, S Lonardi, N Pella, MS Pino, F Urbano, C Antoniotti, ... Clinical Cancer Research 25 (13), 3954-3961, 2019 | 87 | 2019 |
| CDK4/6 inhibitor treatments in patients with hormone receptor positive, Her2 negative advanced breast cancer: potential molecular mechanisms, clinical implications and future … M Roberto, A Astone, A Botticelli, L Carbognin, A Cassano, G D’Auria, ... Cancers 13 (2), 332, 2021 | 57 | 2021 |
| A validated prognostic classifier for V600EBRAF-mutated metastatic colorectal cancer: the ‘BRAF BeCool’study F Loupakis, R Intini, C Cremolini, A Orlandi, A Sartore-Bianchi, ... European Journal of Cancer 118, 121-130, 2019 | 57 | 2019 |
| Neoadjuvant therapy for triple-negative breast cancer: potential predictive biomarkers of activity and efficacy of platinum chemotherapy, PARP-and immune-checkpoint-inhibitors G Garufi, A Palazzo, I Paris, A Orlandi, A Cassano, G Tortora, G Scambia, ... Expert opinion on pharmacotherapy 21 (6), 687-699, 2020 | 54 | 2020 |
| Single-Agent Panitumumab in Frail Elderly Patients With Advanced RAS and BRAF Wild-Type Colorectal Cancer: Challenging Drug Label to Light Up New Hope F Pietrantonio, C Cremolini, G Aprile, S Lonardi, A Orlandi, A Mennitto, ... The Oncologist 20 (11), 1261-1265, 2015 | 50 | 2015 |
| A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation MA Calegari, A Inno, S Monterisi, A Orlandi, D Santini, M Basso, ... British Journal of Cancer 116 (10), 1279-1286, 2017 | 48 | 2017 |
| Targeted therapy in advanced gastric carcinoma: the future is beginning G Schinzari, A Cassano, A Orlandi, M Basso, C Barone Current Medicinal Chemistry 21 (8), 1026-1038, 2014 | 45 | 2014 |
| Smoking habit and hospitalization for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related pneumonia: The unsolved paradox behind the evidence. G Garufi, L Carbognin, A Orlandi, G Tortora, E Bria European journal of internal medicine 77, 121-122, 2020 | 42 | 2020 |
| KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patients M Basso, A Strippoli, A Orlandi, M Martini, MA Calegari, G Schinzari, ... British journal of cancer 108 (1), 115-120, 2013 | 38 | 2013 |
| IL-8 and eNOS polymorphisms predict bevacizumab-based first line treatment outcomes in RAS mutant metastatic colorectal cancer patients M Di Salvatore, F Pietrantonio, A Orlandi, M Del Re, R Berenato, E Rossi, ... Oncotarget 8 (10), 16887, 2017 | 35 | 2017 |
| Automated breast volume scanner (ABVS) compared to handheld ultrasound (HHUS) and contrast-enhanced magnetic resonance imaging (CE-MRI) in the early assessment of breast cancer … A D’Angelo, A Orlandi, E Bufi, S Mercogliano, P Belli, R Manfredi La radiologia medica 126, 517-526, 2021 | 34 | 2021 |
| Trastuzumab-induced corneal ulceration: successful no-drug treatment of a “blind” side effect in a case report A Orlandi, R Fasciani, A Cassano, A Agresta, MA Calegari, A Caporossi, ... BMC cancer 15, 1-3, 2015 | 34 | 2015 |
| Immediate prosthetic breast reconstruction after nipple-sparing mastectomy: traditional subpectoral technique versus direct-to-implant prepectoral reconstruction without … G Franceschini, L Scardina, A Di Leone, DA Terribile, AM Sanchez, ... Journal of Personalized Medicine 11 (2), 153, 2021 | 32 | 2021 |
| Diagnosis and treatment of bone metastases in breast cancer: radiotherapy, local approach and systemic therapy in a guide for clinicians F Marazzi, A Orlandi, S Manfrida, V Masiello, A Di Leone, M Massaccesi, ... Cancers 12 (9), 2390, 2020 | 31 | 2020 |
| Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor‐positive, advanced breast cancer: a real‐world experience L Pizzuti, A Giordano, A Michelotti, M Mazzotta, C Natoli, T Gamucci, ... Journal of Cellular Physiology 234 (6), 7708-7717, 2019 | 25 | 2019 |
| Gemcitabine versus FOLFIRINOX in patients with advanced pancreatic adenocarcinoma hENT1-positive: everything was not too bad back when everything seemed worse A Orlandi, MA Calegari, M Martini, A Cocomazzi, C Bagalà, G Indellicati, ... Clinical and Translational Oncology 18, 988-995, 2016 | 24 | 2016 |
